BTOG Sponsors for 2024

BTOG relies solely on income from exhibition/sponsorship at education events and annual conference registration fees to allow it to support and educate thoracic oncology health care professionals and to undertake key activities under our three strategic arms – education, research and representation. Sponsorship does not constitute endorsement, recommendation, or favouring by BTOG.

These are our sponsors from 1 April 2024 to 31 March 2025.

Diamond Sponsors for 2024

For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd-uk.com and connect with us @MSDintheUK on TwitterInstagramLinkedInYouTube and Facebook.

At Roche UK, we focus our energy and investment in developing tests and treatments that change lives and give us more quality time with the people we love. And, together with others, we’re solving healthcare’s greatest challenges; helping to achieve better results by connecting early diagnosis to targeted treatment and ongoing support.

Healthcare matters to all of us.  That’s why we work hard to ensure that all our new medicines are made available to those who need them through the NHS – wherever they live, whatever their circumstances.

In 2020, more than 820 million Roche diagnostic tests were used to confirm, rule out or manage health conditions and over 712,000 patients benefited from our medicines and diabetes monitoring and insulin delivery system. During this period, we contributed £1.26 billion to the UK economy, supporting over 21,000 jobs.

Proud of what we do, we’re here because we care. In the UK we employ over 2,000 brilliant specialists who work together to transform the lives of patients and their loved ones.

That’s what makes us who we are. That’s what makes us Roche UK. For more information, please visit www.roche.co.uk.

Platinum Sponsors for 2024

For Amgen, the key to serving patients is by being the best possible partner to the NHS and the professionals that fuel it. Over the last 40 years, Amgen has developed innovative medicines in cancer and long-term conditions and is immensely proud of the difference made to the lives of people in the UK through these and the services we deliver alongside them, enabling even more value for the system and patients. Committed to driving sustainable solutions that can adapt to an ever-evolving health system, Amgen is proud to serve its people, customers, and patients every day. www.amgen.co.uk

AstraZeneca is a global, science-driven biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Operating in over 100 countries with its innovative medicines used by millions of patients worldwide, and headquartered in Cambridge, AstraZeneca is based in five different locations across the UK and employs around 8,300 staff across research and development, manufacturing, supply, sales and marketing. For more information, please visit www.astrazeneca.co.uk and follow us on Twitter at @AstraZenecaUK

Bristol Myers Squibb is a global pharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit https://www.bms.com/gb

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics.

The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched the Guardant360® CDx and Guardant360® tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients.

Guardant Health aims to partner to address the needs of healthcare systems and individuals eligible for testing. For more information, please visit http://www.guardanthealth.co.uk.

At Janssen, we envision a world where cancer is a potentially preventable, chronic, or curable disease. To reach this goal, we aim to fundamentally alter the way cancer is understood, diagnosed, and managed. Cancer interception is one of our key strategies for meeting this challenge head on. It means achieving a more robust understanding of the mechanisms involved in the transition of normal cells to a pre-malignant state, offering an opportunity to develop treatments with the potential to stop cancer in its earliest stages.

At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry leading portfolio of over 20 approved innovative cancer medicines and biosimilars in the UK.

In the UK, Pfizer has its business headquarters in Surrey and is a major supplier of medicines to the NHS. To learn more about our commitments, please visit us online at www.Pfizer.co.uk or follow us on Twitter (@Pfizer_UK), Facebook (@PfizerUK) and Instagram (@pfizeruk).

Founded by doctors and scientists over 30 years ago, Regeneron is a leading biotechnology company dedicated to inventing life-transforming medicines to help people with serious diseases.

Our science-driven approach includes research in eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases and rare diseases. In addition, our innovations include the VelociSuite® medicine discovery and development technologies, world-class manufacturing operations, one of the largest human genetics sequencing efforts in the world and rapid response technologies being used for global good.

At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. We ensure a tight connection from research to development to commercialisation to rapidly meet the needs of the cancer community, optimising our ability to bring transformative medicines to patients. Our demonstrated leadership in the treatment of haematologic cancers and solid tumours combined with cutting-edge science through multiple platforms, partnerships and therapeutic approaches enable us to bring novel medicines to patients worldwide. https://www.takeda.com/en-gb/

 

Gold Sponsors for 2024

Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. At Lilly, we are dedicated to developing and delivering innovative medicines that will make a meaningful difference to cancer patients. For us, this means putting an intense focus on the latest scientific advances and collaborating with doctors, other researchers, advocates and payers to ensure our medicines bring value to people living with cancer. People living with cancer are at the centre of what we do. We believe health care makes a difference when striving to improve peoples’ lives. Whether it’s treating rare tumour types, leveraging precision medicine, continuing the study of immuno-oncology or discovering new ways to advance existing treatments, we’re dedicated to making even greater differences in the lives of people living.

 

Merck is a science-led organisation dedicated to delivering transformative medicines with the goal of making a meaningful difference in the lives of patients affected by cancer. Our pioneering spirit drives us to help address this need by discovering and delivering innovative approaches to cancer care.

Our oncology research efforts aim to leverage our synergistic portfolio to tackle challenging tumour types in gastrointestinal, genitourinary, and thoracic cancers.

Learn more at https://www.merckgroup.com/uk-en

 

Silver Sponsors for 2024

 
 
 

The Ion Robotic Bronchsocopy system is a platform for minimally invasive peripheral lung biopsy.

In lung cancer, time to intervention is critical. Ion enables clinical confidence to get early answers and accelerates program impact. Ion delivers meaningful innovation so clinicians can continue to advance care for their lung cancer patients.

Ion’s ultrathin, ultramaneuverable catheter allows clinicians to reach small lesions in all 18 segments of the lung with more reach, precision, and stability.

www.intuitive.com/ion

Irwin Mitchell has been at the forefront of recovering compensation to improve quality of life and provide for the holistic needs of our clients with asbestos diseases for many decades. Our dedicated and compassionate, specialist lawyers, are leaders in their field, have won many landmark cases, including one of the first to fund the costs of private medical treatments, winning many Appeal Court cases over the decades and fighting for positive changes in the law. We support our clients and their healthcare professionals to optimise the quality of life of our clients and their families. To find out how we can help you or your patients, speak with one of our specialist lawyers. We cover the whole of the UK – you can call us on 0808 149 8004 or contact us online www.irwinmitchell.com/.

 
 

Leigh Day has specialised in asbestos cases for over 25 years, both in the UK and around the globe. We advise our clients on a ‘no win, no fee’ basis and they keep 100% of their compensation. Leigh Day lawyers have shaped the law through landmark rulings in the Supreme Court which other law firms follow. A higher number of Leigh Day lawyers are ranked in Band 1 than any other law firm, in the independent legal directory Chambers & Partners. Click to see our Guide: ld-mesothelioma-asbestos-booklet-may23.pdf (leighday.co.uk)

Bronze Sponsors for 2024

In 2023 Fieldfisher marked 40 years working for clients exposed to asbestos. We are leaders in the field and fight for every client to recover the compensation they deserve. While positive news around developing cancer treatments brings hope, a worrying new group of claims involves women exposed to asbestos in talc and beauty products and we watch with interest developments in the US around such claims. We continue to challenge legal precedent in the courts to help future claimants and willingly give our support to charities helping the asbestos disease community, an integral part of our personal and professional lives. https://www.fieldfisher.com/en/injury-claims

Hugh James, is a top 100 law firm with offices in Cardiff, London, Manchester, Southampton, and Plymouth. Established in 1960, it has evolved into a prominent legal entity serving diverse clients across the UK and internationally. The firm’s specialised asbestos solicitors advocate for victims nationwide, boasting over 50 years of expertise in investigating and pursuing asbestos claims. They offer unwavering support to clients and families, simplifying the legal process while relentlessly pursuing justice. Providing expert counsel, they strive for optimal care, treatment, and compensation. With a legacy of excellence, Hugh James remains committed to delivering unparalleled legal services. hughjames.com

RWK Goodman are specialist asbestos claims solicitors offering no win no fee no deductions advice and representation to those diagnosed with asbestos related illnesses.

We can be contacted on 0800 051 8056 or by emailing meso@rwkgoodman.com.

Thompsons Solicitors has regional teams of lawyers across a UK-wide network of offices specialising in mesothelioma, lung cancer and benign asbestos compensation claims.

Thompsons brought the first-ever successful asbestos claim to the House of Lords in 1972. As well as securing the maximum possible compensation, we operate the largest asbestos register in the UK and our experts work alongside support groups providing vital help and advice to individuals and their families.

Since our foundation in 1921 we have, as a point of principle, only ever acted for the injured and never for those who cause harm or their insurers.

Find out more: www.thompsons.law